PRESS RELEASE Oncodesign Biotechnology and Bristol-Myers Squibb enter into Strategic Drug Discovery Collaboration  Collaboration is based on Oncodesign’s Nanocyclix® technology - Monoclonal antibodies - Document - PDFSEARCH.IO

First Page	Meta Content
	PRESS RELEASE Oncodesign Biotechnology and Bristol-Myers Squibb enter into Strategic Drug Discovery Collaboration  Collaboration is based on Oncodesign’s Nanocyclix® technology Add to Reading List Document Date: 2016-01-04 13:50:16 Open Document File Size: 428,21 KB Share Result on Facebook

PRESS RELEASE Oncodesign Biotechnology and Bristol-Myers Squibb enter into Strategic Drug Discovery Collaboration  Collaboration is based on Oncodesign’s Nanocyclix® technologyAdd to Reading List